title: 'Curing' empty follicle syndrome.
abstract: We report a novel method of rescuing empty follicle syndrome (EFS) and provide evidence that it is a drug-related problem rather than a clinical dysfunction. In a preliminary study we established that in EFS the serum beta-human chorionic gonadotrophin (beta-HCG) concentrations 36 h after HCG administration never exceeded 10 mIU/ ml. beta-HCG concentrations were thus used to confirm EFS when oocytes were not retrieved from one ovary after controlled ovarian hyperstimulation. The procedure was suspended leaving intact all follicles in the second, ovary. After confirmation of EFS, a second HCG from a different batch was administered and 36 h later mature oocytes were retrieved from the intact ovary, suggesting a fault with the HCG previously administered. Three patients have been treated in this way. In the first case, four out of five mature eggs were fertilized after intracytoplasmic sperm injection (ICSI) resulting in the transfer of three top grade (grade 1) embryos. In the second case all seven mature oocytes fertilized after in-vitro fertilization (IVF) and three grade 1 embryos were transferred resulting in a twin pregnancy, now delivered. In the third case, five out of nine oocytes were fertilized after ICSI and one out of the three treated with high insemination concentration IVF fertilized, resulting in the transfer of three ICSI embryos.
authors.affiliation: Nottingham University Research and Treatment Unit in Reproduction (NURTURE), Department of Obstetrics and Gynaecology, University Hospital, Queen's Medical Centre, UK.
authors.forename: G
authors.initials: G
authors.lastname: Ndukwe
authors.forename: S
authors.initials: S
authors.lastname: Thornton
authors.forename: S
authors.initials: S
authors.lastname: Fishel
authors.forename: K
authors.initials: K
authors.lastname: Dowell
authors.forename: M
authors.initials: M
authors.lastname: Aloum
authors.forename: S
authors.initials: S
authors.lastname: Green
mesh_terms: D006063:Chorionic Gonadotropin / Q000592:standards* / Q000627:therapeutic use*; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D004624:Embryo Transfer; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D007247:Infertility, Female / Q000473:pathology* / Q000628:therapy; D006080:Ovarian Follicle / Q000473:pathology*; D010062:Ovulation Induction; D011247:Pregnancy; D013577:Syndrome
chemical_list: D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human